Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis
Background:
Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …
Bethesda, United StatesEst. completion Jun 1, 2036
Inflammatory Bowel Disease
Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…
Chicago, United StatesEst. completion Sep 1, 2026
Obesity (Disorder)
The goal of this clinical trial is to understand how gallotannin-rich (GT-rich) mangoes can reduce the inflammatory mark…
Prairie View, United StatesEst. completion Jun 2026
Ulcerative Colitis (UC)
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that requires regular monitoring of disease activity. Cu…
Asyut, EgyptEst. completion Jan 31, 2027
Ulcerative Colitis
The hypothesis of this study is that appropriate time of day of administration of oral, once daily 5-ASA therapy in alig…
Chicago, United StatesEst. completion Aug 30, 2026
Crohn Disease (CD)
This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of standard-dose tumor necrosis …
Guangzhou, ChinaEst. completion Dec 31, 2028
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Colitis
This Phase 2b randomized, double-blind, placebo-controlled, multicenter trial will evaluate the efficacy and safety of a…
Izmir, Turkey (Türkiye)Est. completion May 30, 2027
Inflammatory Bowel Diseases (IBD)Remission of IBDIn AdultsInflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)Crohn's Disease (CD)Ulcerative Colitis (UC)
The VIBRANT-IBD study is a pilot, prospective, single-arm feasibility study investigating the effects of non-invasive va…
Gdansk, PolandCompleted Dec 15, 2026
Ulcerative ColitisIleal Pouch
Ulcerative colitis (UC) is a disease that causes long-term inflammation in the digestive tract, and many people with thi…
Ann Arbor, United StatesEst. completion May 2029
Ulcerative ColitisInflammatory Bowel DiseasesAutoimmune Diseases
The primary objective of this trial is to evaluate the clinical efficacy of ATH-063 in participants with biologic/advanc…
Miami, United StatesEst. completion Dec 14, 2028
Ulcerative ColitisInflammatory Bowel DiseasesColitisColitis, Ulcerative
This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active…
Canoga Park, United StatesEst. completion Jun 2026
Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to s…
Dothan, United StatesEst. completion Oct 30, 2028
Crohn's Disease
The purpose of this study is to evaluate the efficacy of JNJ-78934804 at Week 48 compared to guselkumab and golimumab.
Birmingham, United StatesEst. completion May 23, 2025
Colitis, Ulcerative
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Aug 11, 2028
Colitis, Ulcerative
The purpose of this study is to evaluate the efficacy, including clinical remission of guselkumab subcutaneous (SC) indu…
Litchfield Park, United StatesEst. completion Apr 2, 2024
Crohn Disease
The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to…
Anaheim, United StatesEst. completion Jun 12, 2028
Colitis, Ulcerative
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab…
Arcadia, United StatesEst. completion May 15, 2025
Crohn's Disease
The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 an…
Dothan, United StatesEst. completion Oct 20, 2023
Ulcerative ColitisHealthyIrritable Bowel Syndrome With Diarrhea
This trial is being completed to learn about how Aquamin® affects gastrointestinal permeability, or the control of mater…
Ann Arbor, United StatesCompleted Mar 11, 2024
Ulcerative Colitis
The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment…
Little Rock, United StatesEst. completion Jun 16, 2029